Navigation Links
Bioheart, Inc. to Host Annual Meeting of Shareholders on Wednesday, July 30, 2008
Date:6/6/2008

SUNRISE, Fla., June 6 /PRNewswire-FirstCall/ -- Bioheart, Inc. (Nasdaq: BHRT) will host its 2008 Annual Meeting of Shareholders on Wednesday, July 30, 2008 at Chispa Restaurant, located at 11500 NW 41st Street in Doral, Florida. The meeting will commence at 9:00 am EASTERN.

Interested parties may listen to the Bioheart, Inc. 2008 Annual Meeting via telephone by calling (877) 858-9308 (domestic) or (706) 643-0580 (international). To listen to the Annual Meeting and to view the accompanying slide presentation via the Internet, log onto http://www.bioheartinc.com and click on the 2008 Annual Meeting of Shareholders link. Please note that the broadcast will be listen-only.

An audio only replay of the Annual Meeting will be available at (800) 642- 1687 (domestic) or (706) 645-9291 (international), access number 50330882 for 3 days following the call, and the web cast with slide presentation will be archived on the Company's website, http://www.bioheartinc.com, for 30 days.

About Bioheart, Inc.:

Bioheart, Inc. is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.

Its lead product candidate, MyoCell(R), is an innovative clinical cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. The Company's pipeline includes multiple product candidates for the treatment of heart damage, including Bioheart Acute Cell Therapy, an autologous, adipose-tissue derived stem cell treatment for acute heart damage, and MyoCell(R) SDF-1, a therapy utilizing autologous cells that are genetically modified to express additional potentially therapeutic proteins.

(MyoCell and MyoCell SDF-1 are trademarks of Bioheart, Inc.)

Contact: William Kline Lytham Partners, LLC

Chief Financial Officer Joe Diaz

Nicholas Burke Joe Dorame

VP - Financial Operations Robert Blum

(954) 835-1500 (602) 889-9700


'/>"/>
SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
2. Bioheart, Inc. Announces Financial Results for First Quarter 2008
3. Bioheart, Inc. to Report Full Year 2007 Financial Results on Thursday, March 27, 2008
4. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
5. Hologic to Present at the Needham Seventh Annual Biotechnology and Medical Technology Conference
6. PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
7. Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
8. Trubion Pharmaceuticals to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference
9. Onyx Pharmaceuticals to Present at Goldman Sachs 29th Annual Global Healthcare Conference
10. LeMaitre Vascular to Participate in 29th Annual Goldman Sachs Global Healthcare Conference
11. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... CA (PRWEB) , ... May 23, 2016 , ... ... public interest organization focused on molecular nanotechnology, announced the winners for the 2015 ... pioneer physicist Richard Feynman, are given in two categories, one for experiment and ...
(Date:5/20/2016)... MD (PRWEB) , ... May 20, 2016 , ... The ... with Listeria, as reported by Food Safety News on May 12, 2016(1), demonstrates the ... to Ted Olsen, CEO of Baltimore-based biotech firm, PathSensors, Inc. , ...
(Date:5/19/2016)... 2016 Regen BioPharma, ... RGBPP) announced today initiation of a preclinical development ... based cancer immunotherapeutic product leveraging its NR2F6 immunological ... a generation of cord blood derived killer cells ...  The product in development will be a "universal ...
(Date:5/18/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... kit processing to help them save time and reduce errors. , Sexual Assault kits ... processed and victims informed of results. Due to a previous lack of tools, many ...
Breaking Biology Technology:
(Date:3/10/2016)... March 10, 2016 --> ... research report "Identity and Access Management Market by Component ... and Governance), by Organization Size, by Deployment, by Vertical, ... by MarketsandMarkets, The market is estimated to grow from ... by 2020, at a Compound Annual Growth Rate (CAGR) ...
(Date:3/9/2016)... 9, 2016 Nigeria ... more than 23,000 public service employees either did not ... their salary unlawfully.    --> Nigeria ... that more than 23,000 public service employees either did ... receiving their salary unlawfully.    --> DERMALOG, ...
(Date:3/3/2016)... -- FlexTech, a SEMI Strategic Association Partner, awarded five FLEXI ... Leadership in Education, and, in a category new this ... year of the FLEXI Awards and the winners join ... past years . Judging was done on a set ... by a panel of non-affiliated, independent, industry experts. ...
Breaking Biology News(10 mins):